Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wolfgang Brück & Scott S Zamvil. (2012) Laquinimod, a once-daily oral drug in development for the treatment of relapsing–remitting multiple sclerosis. Expert Review of Clinical Pharmacology 5:3, pages 245-256.
Read now
Read now
Articles from other publishers (25)
Shuqin Tang, Xiangfei Sun, Xinhang Qiao, Wenxuan Cui, Feixiang Yu, Xiaowen Zeng, Adrian Covaci & Da Chen. (2022) Prenatal Exposure to Emerging Plasticizers and Synthetic Antioxidants and Their Potency to Cross Human Placenta. Environmental Science & Technology 56:12, pages 8507-8517.
Crossref
Crossref
Lidia Stork, David Ellenberger, Klemens Ruprecht, Markus Reindl, Tim Beißbarth, Tim Friede, Tania Kümpfel, Lisa A. Gerdes, Mareike Gloth, Thomas Liman, Friedemann Paul, Wolfgang Brück & Imke Metz. (2020) Antibody signatures in patients with histopathologically defined multiple sclerosis patterns. Acta Neuropathologica 139:3, pages 547-564.
Crossref
Crossref
Tim Friede, Harald Pohlmann & Heinz Schmidli. (2019) Blinded sample size reestimation in event‐driven clinical trials: Methods and an application in multiple sclerosis. Pharmaceutical Statistics 18:3, pages 351-365.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2019. The Handbook of Neuroprotection. The Handbook of Neuroprotection
643
766
.
Anna T. Wilmes, Sabrina Reinehr, Sandra Kühn, Xiomara Pedreiturria, Laura Petrikowski, Simon Faissner, Ilya Ayzenberg, Gesa Stute, Ralf Gold, H. Burkhard Dick, Ingo Kleiter & Stephanie C. Joachim. (2018) Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model. Journal of Neuroinflammation 15:1.
Crossref
Crossref
Joo Wan Kim, Jae-Suk Choi, Du Jin Seol, Jai Jun Choung & Sae Kwang Ku. (2018) Immunomodulatory Effects of Kuseonwangdogo-Based Mixed Herbal Formula Extracts on a Cyclophosphamide-Induced Immunosuppression Mouse Model. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-14.
Crossref
Crossref
Yuuki Yamaguchi, Hiroyuki Kanzaki, Yuta Katsumata, Kanako Itohiya, Sari Fukaya, Yutaka Miyamoto, Tsuyoshi Narimiya, Satoshi Wada & Yoshiki Nakamura. (2017)
Dimethyl fumarate inhibits osteoclasts
via
attenuation of reactive oxygen species signalling by augmented antioxidation
. Journal of Cellular and Molecular Medicine.
Crossref
Crossref
N.M.W.J. de Bruin, K. Schmitz, S. Schiffmann, N. Tafferner, M. Schmidt, H. Jordan, A. Häußler, I. Tegeder, G. Geisslinger & M.J. Parnham. (2016) Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis. Behavioural Brain Research 300, pages 160-174.
Crossref
Crossref
Thomas Hanke, Daniel Merk, Dieter Steinhilber, Gerd Geisslinger & Manfred Schubert-Zsilavecz. (2016) Small molecules with anti-inflammatory properties in clinical development. Pharmacology & Therapeutics 157, pages 163-187.
Crossref
Crossref
Daniel Merk. (2015) Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment. Future Medicinal Chemistry 7:18, pages 2411-2413.
Crossref
Crossref
Rachel Hutchins Thomas & Richard A. Wakefield. (2015) Oral disease-modifying therapies for relapsing-remitting multiple sclerosis. American Journal of Health-System Pharmacy 72:1, pages 25-38.
Crossref
Crossref
Yuxiu Zhang, Dongmei Cun, Xin Kong & Liang Fang. (2014) Design and evaluation of a novel transdermal patch containing diclofenac and teriflunomide for rheumatoid arthritis therapy. Asian Journal of Pharmaceutical Sciences 9:5, pages 251-259.
Crossref
Crossref
Kyoung Song, In-Soo Yoon, Nam Ah Kim, Dong-Hwan Kim, Jongmin Lee, Hee Jung Lee, Saehyung Lee, Sunghyun Choi, Min-Koo Choi, Ha Hyung Kim, Seong Hoon Jeong, Woo Sung Son, Dae-Duk Kim & Young Kee Shin. (2014) Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties. PLoS ONE 9:5, pages e96967.
Crossref
Crossref
Zhengyu Zhu, Wei You, ZhaoHong Xie, Ping Wang, Zhen Liu, Cunfu Wang & JianZhong Bi. (2014) Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis. Journal of International Medical Research 42:2, pages 530-541.
Crossref
Crossref
Masaaki Niino & Yusei Miyazaki. (2014) Individualizing therapy for multiple sclerosis: a focus on disease-modifying drugs. Clinical Practice 11:1, pages 105-115.
Crossref
Crossref
Mark S. Freedman. (2013) Present and Emerging Therapies for Multiple Sclerosis. CONTINUUM: Lifelong Learning in Neurology 19, pages 968-991.
Crossref
Crossref
Honglei Xi, Dongmei Cun, Rongwu Xiang, Yanli Guan, Yuxiu Zhang, Yuanru Li & Liang Fang. (2013) Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: Does the topical patch really enhance a local treatment?. Journal of Controlled Release 169:1-2, pages 73-81.
Crossref
Crossref
Aran Groves, Yasuyuki Kihara & Jerold Chun. (2013) Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. Journal of the Neurological Sciences 328:1-2, pages 9-18.
Crossref
Crossref
Jeremy J. Edmunds. 2013. Drug Discovery. Drug Discovery
337
388
.
Richard Nicholas & Tim Friede. (2012) Considerations in the design of clinical trials for relapsing multiple sclerosis. Clinical Investigation 2:11, pages 1073-1083.
Crossref
Crossref
Jacques Descotes. (2012) Safety immunopharmacology: Evaluation of the adverse potential of pharmaceuticals on the immune system. Journal of Pharmacological and Toxicological Methods 66:2, pages 79-83.
Crossref
Crossref
Franz Fazekas. (2012) Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert GroupFingolimod im Behandlungsalgorithmus der schubförmigen Multiplen Sklerose: Eine Stellungnahme der mittel- und osteuropäischen MS ExpertInnengruppe. Wiener Medizinische Wochenschrift 162:15-16, pages 354-366.
Crossref
Crossref
Milena De Riz, Daniela Galimberti & Elio Scarpini. (2012) Disease-modifying drugs in multiple sclerosis: new oral options. Clinical Practice 9:3, pages 315-327.
Crossref
Crossref
Irena Lavrnja, Danijela Savic, Ivana Bjelobaba, Sanja Dacic, Iva Bozic, Ana Parabucki, Nadezda Nedeljkovic, Sanja Pekovic, Ljubisav Rakic & Mirjana Stojiljkovic. (2012) The Effect of Ribavirin on Reactive Astrogliosis in Experimental Autoimmune Encephalomyelitis. Journal of Pharmacological Sciences 119:3, pages 221-232.
Crossref
Crossref
Ghaniah Hassan-Smith & Michael R Douglas. (2011) Management and prognosis of multiple sclerosis. British Journal of Hospital Medicine 72:Sup11, pages M174-M176.
Crossref
Crossref